ESR1 and breast carcinoma: In particular, triple-negative breast cancer (TNBC; ER, PR and HER negative (ER−PR−HER−)), a highly aggressive breast cancer subtype lacking ER, PR and HER2, is difficult to treat owing to the absence of these receptors5.